Does TACROLIMUS Cause Polyomavirus-associated nephropathy? 1,477 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,477 reports of Polyomavirus-associated nephropathy have been filed in association with TACROLIMUS (Tacrolimus). This represents 1.6% of all adverse event reports for TACROLIMUS.
1,477
Reports of Polyomavirus-associated nephropathy with TACROLIMUS
1.6%
of all TACROLIMUS reports
86
Deaths
435
Hospitalizations
How Dangerous Is Polyomavirus-associated nephropathy From TACROLIMUS?
Of the 1,477 reports, 86 (5.8%) resulted in death, 435 (29.5%) required hospitalization, and 83 (5.6%) were considered life-threatening.
Is Polyomavirus-associated nephropathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TACROLIMUS. However, 1,477 reports have been filed with the FAERS database.
What Other Side Effects Does TACROLIMUS Cause?
Off label use (8,718)
Drug ineffective (6,214)
Product use in unapproved indication (5,057)
Acute kidney injury (4,005)
Transplant rejection (3,526)
Cytomegalovirus infection (3,320)
Covid-19 (3,201)
Drug interaction (2,896)
Diarrhoea (2,854)
Toxicity to various agents (2,845)
What Other Drugs Cause Polyomavirus-associated nephropathy?
MYCOPHENOLATE MOFETIL (1,112)
PREDNISONE (666)
METHYLPREDNISOLONE (416)
PREDNISOLONE (402)
BASILIXIMAB (298)
EVEROLIMUS (247)
CYCLOSPORINE (246)
MYCOPHENOLIC ACID (238)
RITUXIMAB (236)
SIROLIMUS (161)
Which TACROLIMUS Alternatives Have Lower Polyomavirus-associated nephropathy Risk?
TACROLIMUS vs TACROLIMUS\TACROLIMUS ANHYDROUS
TACROLIMUS vs TADALAFIL
TACROLIMUS vs TAFAMIDIS
TACROLIMUS vs TAFAMIDIS MEGLUMINE
TACROLIMUS vs TAFASITAMAB